Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/2597
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | GEUSENS, Piet | - |
dc.contributor.author | Landewe, R | - |
dc.contributor.author | Dunstan, C | - |
dc.contributor.author | Gaenero, P | - |
dc.contributor.author | van der Linden, S | - |
dc.contributor.author | Boers, M | - |
dc.date.accessioned | 2007-11-15T13:11:42Z | - |
dc.date.available | 2007-11-15T13:11:42Z | - |
dc.date.issued | 2002 | - |
dc.identifier.citation | ARTHRITIS AND RHEUMATISM, 46(9). p. S388-S388 | - |
dc.identifier.issn | 0004-3591 | - |
dc.identifier.uri | http://hdl.handle.net/1942/2597 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-LISS | - |
dc.title | Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression. | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | S388 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | S388 | - |
dc.identifier.volume | 46 | - |
local.format.pages | 1 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | Limburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp, Maastricht, Netherlands. Amgen Inc, Thousand Oaks, CA USA. INSERM, F-69008 Lyon, France. VU Univ Hosp, Amsterdam, Netherlands. | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.bibliographicCitation.oldjcat | A5 | - |
dc.identifier.isi | 000178421801036 | - |
item.fulltext | No Fulltext | - |
item.accessRights | Closed Access | - |
item.contributor | GEUSENS, Piet | - |
item.contributor | Landewe, R | - |
item.contributor | Dunstan, C | - |
item.contributor | Gaenero, P | - |
item.contributor | van der Linden, S | - |
item.contributor | Boers, M | - |
item.fullcitation | GEUSENS, Piet; Landewe, R; Dunstan, C; Gaenero, P; van der Linden, S & Boers, M (2002) Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.. In: ARTHRITIS AND RHEUMATISM, 46(9). p. S388-S388. | - |
crisitem.journal.issn | 0004-3591 | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.